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The s age of disease in human immunodeficiency virus ype virus RNA load in serum and on cellular infec ious load was analyzed for pa ien s receiving an iviral herapy. 1 (HIV-1) -infec ed persons is associa ed wi h he level of virus in serum or plasma and he level of cell-associa ed virus [1 -4] . In addi ion, plasma levels of HIV-1 RNA early in infec ion Subjects and Methods are predic ive of he ra e of progression [5] . This la er finding, oge her wi h he fac ha RNA load in plasma direc ly reflec s Group A consis ed of 23 par icipan s of he Ams erdam Cohor S udies on AIDS (ACS). Fif een subjec s en ered ACS while s ill viral replica ion [6, 7] , favored plasma RNA load as a progresseronega ive for HIV-1 an ibodies. Eigh par icipan s were already sion marker in HIV-1 infec ion and as a marker for ini ia ion seroposi ive a heir firs visi , and he seroconversion da e of hese and evalua ion of an iviral herapy.
persons was es ima ed o be 18 mon hs before en ry in o ACS.
Al hough bo h HIV-1 RNA levels in serum or plasma and Fif een par icipan s progressed o AIDS af er an asymp oma ic frequencies of produc ively infec ed cells correla e wi h CD4 phase ranging from 2.8 o 11.3 years. Eigh subjec s classified as T cell decline and disease progression, heir emporal rela ionlong-erm survivors were s ill asymp oma ic af er 10.2-13.7 years ship is no fully unders ood. Therefore, we longi udinally comand had s able CD4 T cell coun s of ú400/mL a leas un il year pared virus RNA load in sera and infec ious load in peripheral 9 of follow-up.
CD4 T cells from a he erogenous group consis ing of longGroup B consis ed of 22 pa ien s who were par icipa ing in ACS erm survivors of HIV-1 infec ion and slow or rapid progressors or visi ing he Academic Medical Cen re AIDS clinic. Changes in serum HIV-1 RNA levels and in frequencies of produc ively ino AIDS, ei her in he absence or presence of syncy ium-inducfec ed cells were moni ored during rea men wi h zidovudine (n ing (SI) HIV-1 varian s. In addi ion, he effec of rea men on Å 10), didanosine (n Å 6), a combina ion of zidovudine and didanosine (n Å 2), or ri onavir (n Å 4).
Da a were available for all par icipan s as a resul of ongoing Received 24 January 1997; revised 9 June 1997. research in our labora ory, and no specific selec ion was made.
Wri en informed consen was ob ained from all par icipan s. In he conduc
The biologic pheno ype of HIV-1 and frequencies of producof clinical research, human experimen a ion guidelines of he au hors' ins i uively infec ed CD4 T cells were de ermined by cocul iva ion of ions were followed. receiving zidovudine and didanosine combina ion herapy or ri o-navir were de ermined by use of reverse-ranscrip ase polymerase chain reac ion (Amplicor HIV-1 moni or assay; Roche Molecular Sys ems, Branchburg, NJ). RNA levels in plasma and in serum ha are measured by NASBA correla e very well, wi h RNA levels in plasma being, on average, 0.5 log higher han hose in serum [8] . For he par icipan s receiving zidovudine and didanosine combina ion herapy, he number of proviral HIV-1 DNA copies in PBMC was de ermined using a compe i ive quan i a ive polymerase chain reac ion [9] . The correla ion be ween serum RNA load and cellular infec ious load was analyzed in 252 paired serum and cryopreserved PBMC samples derived from he subjec s in groups A and B and from 9 addi ional persons, from whom only samples from a single ime poin were analyzed (n Å 54). To avoid bias caused by repea ed measuremen s for 1 person, he median of he paired measuremen s was de ermined for each person, and he correla ion be ween he log-ransformed load values was analyzed by use of Pearson's correla ion coefficien (r p ). In cases in which he number of samples was small, Spearman's correla ion coefficien (r s ) was used. The wo-ailed Fisher's exac es and he Mann-Whi ney U es were used o analyze he rela ionship be ween he frequency of produc ively infec ed CD4 T cells or serum RNA copies early in infec ion and he occurrence of and ime o an AIDS diagnosis.
Results
Cross-sectional analysis of RNA load and cellular infectious load. Virus load was analyzed in 252 paired serum and PBMC samples from 54 pa ien s. Analysis of he median of paired measuremen s of all par icipan s revealed a s a is ically significan correla ion be ween HIV-1 RNA levels in serum and he frequency of produc ively infec ed cells (n Å 54, r p Å .52, P õ.001) (figure 1A). Analysis of subgroups of samples, s ra ified by rea men and s age of disease, indica ed ha bo h measures of virus load were highly correla ed in he period be ween he firs 18 mon hs of follow-up and AIDS diagnosis (n Å 43, r p Å .71, P õ .001) and during rea men (n Å 26, r p Å .78, P õ .001). However, nei her measure of virus load correla ed in he firs 18 mon hs of follow-up (n Å 18, r s Å .06, P Å .8) or in he period af er an AIDS diagnosis (n Å 8, r s Å 0.05, P Å .9).
S ra ifica ion of he samples by he absence or presence of SI varian s showed a similar correla ion be ween bo h measures of virus load in persons harboring bo h non-SI and SI varian s up un il AIDS diagnosis or o he end of follow-up (mean ime, Figure 2 . Longi udinal analysis of HIV-1 RNA levels in sera and frequencies of producively infec ed CD4 T cells (TCID/10 6 CD4 T cells) during na ural course of infec ion (A) and during an iviral rea men (B). A, For each pa ern described in ex , 1 represen a ive is given: I, Bo h measures of virus load remain s able a low levels (n Å 5); II, bo h measures of virus load remain s able a modera e o high levels (n Å 4); III, bo h measures of virus load increase (n Å 9); and IV, RNA levels in sera remain s able and frequencies of produc ively infec ed cells increase (n Å 5). ᭢ Å ime of AIDS diagnosis; Ç Å ime syncy ium-inducing varian s appeared. B, Represen s persons rea ed wi h zidovudine (I; n Å 10), didanosine (II; n Å 6), ri onavir (III; n Å 4), or zidovudine and didanosine in combina ion (IV; n Å 2). In persons receiving bo h zidovudine and didanosine, proviral DNA load in CD4 T cells was also measured.
5.3 years; range, 2.0 -9.4), (1) bo h measures remained s able progressive clinical course (12/13 were progressors). Of he 5 persons in whom RNA load remained s able a modera e o (õ1 log increase and/or õ10 4 RNA copies/mL of serum or õ30 TCID/10 6 CD4 T cells a he end of follow-up; n Å 9); high levels while he cellular infec ious load increased, 2 were long-erm survivors and 3 progressed o AIDS wi hin 2.8 -5.5 (2) bo h measures increased (ú1 log; n Å 9); or (3) he cellular infec ious load increased while he RNA load remained s able years. In mos pa ien s (18/22) rea ed wi h differen an i -HIV-1 drugs (group B), changes in serum RNA load and cellular (n Å 5; figure 2A ).
Main enance of low levels of bo h measures of virus load infec ious load were similar. For bo h persons rea ed wi h he combina ion of zidovudine and didanosine, proviral DNA was was associa ed wi h long-erm survival (5/5 were long-erm survivors). S able ye modera e o high levels (10 4 -10 6 RNA addi ionally quan ified bu showed no change ( figure 2B ).
Predictive value of early virus load measures. In 22 par icicopies/mL of serum and 50 -70 TCID/10 6 CD4 T cells) or an increase in bo h measures of virus load was associa ed wi h a pan s from group A, cellular infec ious load was measured a leas once be ween follow-up mon hs 10 and 26. These persons PBMC, only represen s a minor frac ion of he o al virus popula ion in he same PBMC. However, his quasispecies is he were classified in o 2 groups according o heir cellular infecious load during his period. Persons in group 1 (n Å 12) had major sequence in he o al virus popula ion presen in PBMC isola ed 6 mon hs la er in infec ion [11] . Whe her a any mo-õ10 TCID/10 6 CD4 T cells; persons in group 2 (n Å 10) had §10 TCID/10 6 CD4 T cells. men in ime he infec ious virus popula ion in PBMC is iden ical o he virus popula ion in RNA is curren ly under inves igaThe number of par icipan s who were seroposi ive a en ry was higher in group 1; as a resul , he mean ime poin of ion.
In accordance wi h he previously described correla ion beanalysis in rela ion o he es ima ed seroconversion da e was la er in group 1 (30 mon hs; range, 16 -42) han in group 2 ween he ra e of progression and plasma RNA load early in infec ion [5] , we found ha bo h he cellular infec ious load (18 mon hs; range, 10 -34). In group 1, 7 persons s ill had no progressed o AIDS af er 10 -12 years of follow-up. Of he 5
and serum RNA load in he firs 1 -2 years of follow-up were predic ive for he leng h of he asymp oma ic phase. persons in group 1 who progressed o AIDS, he mean incubaion ime was 7.2 years (range, 5.2 -11.3). Nine of 10 persons
The s rong correla ion be ween cellular infec ious load and RNA load in serum subs an ia es he use of RNA quan i a ion in group 2 progressed o AIDS wi hin a mean of 4.4 years (range, 2.8 -5.9). The 2 groups differed significan ly wi h rein moni oring disease progression and herapy. Quan i a ion of cellular infec ious load, however, would provide addi ional spec o he chance of progressing o AIDS (odds ra io Å 12.6, 95% confidence in erval Å 1.2 -134.0, P Å .03) and wi h relevan informa ion because i reveals he presence of minor varian s and he con ribu ion of dis inc varian s o he virus respec o he mean ime o an AIDS diagnosis in hose who progressed o AIDS (P Å .03).
load even when he load is very low. In some persons, dis inc pa erns in bo h measures of virus Similarly, s ra ifica ion by virus RNA levels below or above 10 4 copies/mL of serum showed a correla ion be ween early load were observed. In all hese cases, he cellular infec ious load gradually increased, while he RNA load reached modera e RNA levels and disease progression (odds ra io Å 17.5, 95% confidence in erval Å 1.6 -192.1, P Å .02) and ime o AIDS o high levels wi hin 12 -18 mon hs of follow-up and subsequen ly remained s able. The resul ing large discrepancies be-(P Å .04).
ween bo h measures of virus load in his period and high fluc ua ions in RNA load seen early in infec ion in some perDiscussion sons migh con ribu e o he absence of a correla ion be ween bo h measures of virus load in he firs 18 mon hs of followIn he presen s udy, cross-sec ional analysis revealed a s rong correla ion be ween serum HIV-1 RNA levels and celluup. A s able RNA load in serum in he presence of an increasing lar infec ious load in he period af er 18 mon hs follow-up un il AIDS diagnosis and during an iviral herapy. Moreover, he cellular infec ious load in he periphery migh reflec a change in he ra io of noninfec ious versus infec ious virus par icles, kine ics of changes in bo h measures of virus load were similar over ime in he majori y (78%) of persons s udied during he wi h he appearance of rela ively increased infec ious virus in la er s ages of infec ion. The increase in infec ed cells in periphna ural course of infec ion and he majori y (82%) of persons undergoing rea men . eral blood migh also resul from an al era ion in lymphocy e dis ribu ion. During infec ion, he lymph node archi ec ure is The finding ha changes in RNA load in serum and cellular infec ious load in peripheral blood generally coincide sugges s los [12] , which migh resul in leakage of infec ed cells from he lymph nodes. Fur hermore, an increase in he cellular infecha PBMC and serum represen he same, or a leas closely rela ed, virus compar men s. Moreover, he simul aneous ocious load in peripheral blood migh be explained by an increase in he number of arge cells. Since he differen chemokine currence of rebound o baseline levels in serum RNA and frequencies of produc ively infec ed cells in mos rea ed perrecep ors used as cofac ors for HIV-1 en ry [13, 14] are expressed in differen quan i ies on T cells [15, 16] , evolu ion of sons sugges s ha he urnover kine ics of cellular infec ious load are similar o hose repor ed for viral RNA in plasma HIV-1 varian s wi h al ered corecep or usage and also evolu ion of varian s wi h higher corecep or affini y migh resul in an [6, 7] .
This seems o con ras wi h he finding ha mu a ions in increased arge cell popula ion. In his ligh , a dis inc pa ern in serum RNA load and cellular infec ious load can be envi-HIV-1 RNA precede he appearance of hese mu a ions in proviral DNA [10] . However, he absence of a response o an iviral sioned o resul from al ered corecep or usage coinciding wi h a more cy opa hic pheno ype. This would resul in a higher rea men in he proviral DNA load in PBMC sugges s differen urnover kine ics in he produc ively infec ed and he o al frequency of produc ively infec ed cells ye simul aneously in a decreased half-life of infec ed cells and he amoun of virus infec ed cell popula ions, which may be due o a longer halflife of cells carrying defec ive HIV-1. The no ion ha he kineproduced per cell. We were surprised o find declining CD4 T cell coun s in ics of he o al virus popula ion lag behind hose of he infecious virus popula ion is suppor ed by he finding ha he viral half (7/15) of he par icipan s wi h progressive disease, while ei her virus RNA load in serum or bo h RNA load and cellular quasispecies, which predomina es af er cocul iva ion of pa ien
